BIS Invests in R&D to Drive Standardisation
The Bureau of Indian Standards (BIS) has announced the sanction of 82 research and development (R&D) projects to bolster its standardisation efforts. These projects, awarded to faculty members from institutions like IITs and NITs, will focus on cutting-edge domains such as artificial intelligence, blockchain technology, medical devices, renewable energy, and sustainability.
Ayurveda Research Meets Industry at PRAGATI-2024
The interactive meeting aims to explore research opportunities and collaborations between CCRAS and the Ayurveda drug industry. It also aims to maximize the potential of Ayurveda stakeholders by connecting researchers with industry partners. Ultimately, it will also benefit Ayurvedic practitioners and patients.
Institute of Teaching and Research in Ayurveda, Doctor of Philosophy Regulations, 2024
Under these regulations, all matters concerning the Ph.D. program at the Institute will be overseen by Research Committees, with general supervision from the Governing body. Applicants for the doctoral program will be classified into various categories based on their funding source or employment status. Admissions to the Ph.D. program will be conducted annually, with entrance tests typically held in October-November. The Institute will publish an academic calendar specifying all important dates related to the admission process, including advertisement, application submission, and entrance test results.
WHO to Include Ayurveda, Siddha, Unani Morbidity Codes
The ICD series by WHO serves as a global standard for classifying diseases, providing a common language for health information. While the existing data primarily reflects modern biomedical practices, the upcoming ICD 11 TM Module 2 aims to incorporate data and terminology from Ayurveda, Siddha, and Unani (ASU) systems, bringing global uniformity to the classification of traditional medicine.
SMART 2.0 Launched For Ayurveda Teaching Professionals
SMART 2.0 is an acronym for ‘Scope for Mainstreaming Ayurveda Research among Teaching professionals.’ It aims to facilitate robust clinical studies in priority areas of Ayurveda through collaboration with academic institutions and hospitals nationwide. Academic institutions interested in participating in collaborative research activities can submit their ‘Expression of Interest’.
MedTech Mitra Launched To Empower Innovators in Healthcare
Acknowledging the import dependency of India’s MedTech sector, which stands at 80%, the Minister underscored the progress made through production-linked incentive schemes, investments in medical drug parks, and the implementation of the MedTech research policy and incentive scheme. The collaborative initiative of ‘MedTech Mitra’ is expected to drive indigenous development, making quality MedTech devices more affordable and reducing import dependence.
Directives on Healthcare Professionals’ Involvement in E-Cigarette and HTP Research
The directive emphasizes that healthcare professionals associated with the NMC and IMA should refrain from initiating or participating in any research activities related to e-cigarettes and HTPs without obtaining the necessary approvals from the Directorate General of Health Services (Dte.GHS) and MoHFW.
New Regulations Set Standards for Medical Research in Indian System of Medicine
These regulations aim to ensure the highest standards in conducting medical research within the Indian System of Medicine, promoting ethical practices, transparency, and scientific rigor. Researchers and stakeholders are expected to adhere to these guidelines for the advancement of research in the field.
NMC Calls for Expertise in Developing Specialized Medical Library
The success of this initiative relies on the collaborative efforts of experts in the field, and the NMC is confident that their commitment and knowledge will contribute significantly to the establishment of a world-class resource for medical education and research.
India and Netherlands Collaborate on Medical Product Regulation
India and Netherlands have formalized their commitment to enhance medical product regulation and elevate the quality of healthcare services through a Memorandum of Intent (MoI). The collaboration aims to foster cooperation in pharmaceutical and medical technology industries, a significant stride towards global health goals.
